Merck & Co., Inc. 10-Q Filing

From the Filing

0000310158-25-000059.txt : 20251105 0000310158-25-000059.hdr.sgml : 20251105 20251105160841 ACCESSION NUMBER: 0000310158-25-000059 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 97 CONFORMED PERIOD OF REPORT: 20250930 FILED AS OF DATE: 20251105 DATE AS OF CHANGE: 20251105 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Merck & Co., Inc. CENTRAL INDEX KEY: 0000310158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 221918501 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-06571 FILM NUMBER: 251453989 BUSINESS ADDRESS: STREET 1: 126 EAST LINCOLN AVENUE STREET 2: P.O. BOX 2000 CITY: RAHWAY STATE: NJ ZIP: 07065 BUSINESS PHONE: 908-740-4000 MAIL ADDRESS: STREET 1: 126 EAST LINCOLN AVENUE STREET 2: P.O. BOX 2000 CITY: RAHWAY STATE: NJ ZIP: 07065 FORMER COMPANY: FORMER CONFORMED NAME: Merck & Co. Inc. DATE OF NAME CHANGE: 20091103 FORMER COMPANY: FORMER CONFORMED NAME: SCHERING PLOUGH CORP DATE OF NAME CHANGE: 19920703 10-Q 1 mrk-20250930.htm 3Q25 FORM 10-Q mrk-20250930 FALSE 2025 Q3 0000310158 12/31 http://fasb.org/us-gaap/2025#LongTermDebtNoncurrent http://fasb.org/us-gaap/2025#LongTermDebtNoncurrent http://fasb.org/us-gaap/2025#OtherAssetsNoncurrent http://fasb.org/us-gaap/2025#OtherAssetsNoncurrent http://fasb.org/us-gaap/2025#OtherAssetsCurrent http://fasb.org/us-gaap/2025#OtherAssetsCurrent http://fasb.org/us-gaap/2025#OtherAssetsNoncurrent http://fasb.org/us-gaap/2025#OtherAssetsNoncurrent http://fasb.org/us-gaap/2025#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2025#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2025#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2025#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2025#OtherAssetsCurrent http://fasb.org/us-gaap/2025#OtherAssetsCurrent http://fasb.org/us-gaap/2025#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2025#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2025#OtherNonoperatingIncomeExpense http://fasb.org/us-gaap/2025#OtherNonoperatingIncomeExpense 24 xbrli:shares iso4217:USD iso4217:USD xbrli:shares mrk:aqua_facility xbrli:pure mrk:candidate mrk:interest_rate_swap mrk:case mrk:plaintiff mrk:motion mrk:company mrk:patent mrk:segment 0000310158 2025-01-01 2025-09-30 0000310158 us-gaap:CommonStockMember 2025-01-01 2025-09-30 0000310158 mrk:A1.875Notesdue2026Member 2025-01-01 2025-09-30 0000310158 mrk:A3.250NotesDue2032Member 2025-01-01 2025-09-30 0000310158 mrk:A2.500Notesdue2034Member 2025-01-01 2025-09-30 0000310158 mrk:A1.375Notesdue2036Member 2025-01-01 2025-09-30 0000310158 mrk:A3.500NotesDue2037Member 2025-01-01 2025-09-30 0000310158 mrk:A3.700NotesDue2044Member 2025-01-01 2025-09-30 0000310158 mrk:A3.750NotesDue2054Member 2025-01-01 2025-09-30 0000310158 2025-10-31 0000310158 2025-07-01 2025-09-30 0000310158 2024-07-01 2024-09-30 0000310158 2024-01-01 2024-09-30 0000310158 2025-09-30 0000310158 2024-12-31 0000310158 2023-12-31 0000310158 2024-09-30 0000310158 mrk:Dr.FalkPharmaMember srt:ScenarioForecastMember 2025-10-01 2025-12-31 0000310158 mrk:VeronaPharmaPlcMember us-gaap:SubsequentEventMember 2025-10-01 2025-10-31 0000310158 srt:ScenarioForecastMember mrk:SacTMTMember 2025-10-01 2025-10-31 0000310158 mrk:LaNovaMedicinesLtdMember 2025-07-01 2025-09-30 0000310158 mrk:LaNovaMedicinesLtdMember 2025-01-01 2025-09-30 0000310158 mrk:HRS5346JiangsuHengruiPharmaceuticalsCo.Ltd.Member 2025-01-01 2025-09-30 0000310158 mrk:JiangsuHengruiPharmaceuticalsCo.Ltd.Member 2025-05-31 0000310158 mrk:WuXiVaccinesFacilityMember 2025-03-01 2025-03-31 0000310158 mrk:WuXiVaccinesFacilityMember us-gaap:AssetUnderConstructionMember 2025-03-31 0000310158 mrk:MK1045CN201CuronBiopharmaceuticalMember 2024-09-01 2024-09-30 0000310158 mrk:MK1045CN201CuronBiopharmaceuticalMember 2024-09-30 0000310158 mrk:MK1045CN201CuronBiopharmaceuticalMember 2024-07-01 2024-09-30 0000310158 mrk:MK1045CN201CuronBiopharmaceuticalMember 2024-01-01 2024-09-30 0000